Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance?

Enomoto, Masaru; Vutien, Philip; Kawada, Norifumi

Enomoto, Masaru; Vutien, Philip; Kawada, Norifumi.

Enomoto M; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Vutien P; Division of Gastroenterology and Hepatology, University of Washington, Seattle, WA.
Kawada N; Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.

Hepatol Commun ; 6(3): 445-447, 2022 03.

Article in English | MEDLINE | ID: covidwho-1706945

Subject(s)

Carcinoma, Hepatocellular; Liver Neoplasms; Carcinoma, Hepatocellular/epidemiology; Humans; Liver Cirrhosis/diagnosis; Liver Neoplasms/epidemiology; Sustained Virologic Response

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Hepatol Commun Year: 2022 Document Type: Article Affiliation country: Hep4.1864

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google